MetaCap

Instil Bio Insider Trades

NASDAQ: TILHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

6.74+0.18 (+2.74%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Instil Bio insider activity

No Instil Bio insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Laumas Sandeep (CFO and CBO) reporting a transaction in 17,000 shares at $11.60 on Sep 10, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TIL's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TIL insider transactions

Instil Bio insider transactions
DateInsiderTypeSharesValueFiling
Sep 10, 2025Laumas SandeepCFO and CBOSale12,461$297.57KForm 4
Sep 10, 2025Laumas SandeepCFO and CBOSale17,539$404.10KForm 4
Sep 10, 2025Laumas SandeepCFO and CBOOption exercise13,000$164.84KForm 4
Sep 10, 2025Laumas SandeepCFO and CBOOption exercise17,000$197.20KForm 4
Mar 15, 2022McGaughy R Kent JrDirectorother260,323—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related